A Detailed Study of Covid-19 (Emphasizing its Genomic Variants, Pathogenicity, Phylogenetic Analysis, Epidemiology, and Clinical Measures)

Keywords: Variants, Outbreak, Antiviral Therapies, SARS-CoV2


Covid-19 (Coronavirus) had spread all over the world. Around 213 countries were affected by the deadly virus and encountered a mob of dead. After analyzing the genome, we can say that the Coronavirus originates in bats and gets transmitted to humans. Although the intermediate source of origin and transmission to humans is unknown, rapid human-to-human transmission has been evinced. SARS-CoV-2 is phylogenetically related to a group of bat viruses known to cause severe acute respiratory syndrome (SARS-CoV). Both viruses (SARS-CoV and SARS-CoV2) belong to the same family of beta coronaviruses. The first case of SARS-CoV2 infection was reported from Wuhan, China. Till now, there have been 577,018,226 confirmed cases of Covid-19 worldwide. More than 6 million people have succumbed to this deadly disease worldwide. Presently, the urgent need to develop a drug and vaccine that could cure this disease is fulfilled. This current review summarizes the origin of SARS-CoV2, its genome structure, pathogenicity and phylogenetic analysis of the virus, and its epidemiology. We have also discussed the existing drugs and approved vaccines that are presently treating humanity. This review aims to compact every possible information regarding Covid-19.


Download data is not yet available.

Author Biographies

Somenath Dutta

Pondicherry Central University, Puducherry, 605014, India.

Rohan Ghosh

Pondicherry Central University, Puducherry, 605014, India. 

Debanjan Ghosh

Pondicherry Central University, Puducherry, 605014, India. 

Priyasa Santra

Pondicherry Central University, Puducherry, 605014, India

Shilpa Daw

Sharabeshwara College of Nursing, Karnataka, 583102, India. 


Wang LF, Shi Z, Zhang S, Field H, Daszak P, Eaton B. Review of Bats and SARS. Emerging Infectious Diseases 2006;12(12):1834–40. https://doi.org/10.3201/eid1212.060401.

Chen Y, Guo D. Molecular mechanisms of coronavirus RNA capping and methylation. Virol Sin. 2016;31(1):3–11. https://doi.org/10.1007/s12250-016-3726-4.

Ge X-Y et al., Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 2013; 503(7477):535–8. https://doi.org/ 10.1038/nature12711.

Drexler JF, Corman VM, Drosten C. Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS. Antiviral Research 2014; 101: 45–56. https://doi.org/10.1016/j.antiviral.2013.10.013.

Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses, Nature Reviews Microbiology. 2019; 17(3):181–92. https://doi.org/ 10.1038/s41579-018-0118-9.

Risk assessment: Outbreak of acute respiratory syndrome associated with a novel coronavirus, Wuhan, China; first update, https://www.ecdc.europa.eu/en/publications-data/risk-assessment-outbreak-acute-respiratory-syndrome-associated-novel-coronavirus. European Centre for Disease Prevention and Control, Jan. 22, 2020.

Holmes E. Initial genome release of novel coronavirus 2020, Jan. 14, 2020.

Guan W et al., Clinical Characteristics of Coronavirus Disease 2019 in China, New England Journal of Medicine, vol. 382, no. 18, pp. 1708–1720, Apr. 2020, https://doi.org/10.1056/NEJMoa2002032.

Guo YR et al., The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res. 2020;7(1):11. https://doi.org/10.1186/s40779-020-00240-0.

Lu R et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, The Lancet 2020; 395(10224):565–74. https://doi.org/10.1016/S0140-6736(20)30251-8.

Tang X et al., On the origin and continuing evolution of SARS-CoV-2. National Science Review 2020; 7(6):1012–23. https://doi.org/10.1093/nsr/nwaa036.

Cui J, Li F, Shi ZL, Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiologyn 2019;17(3):181–92. https://doi.org/10.1038/s41579-018-0118-9.

Woo PCY et al., Discovery of Seven Novel Mammalian and Avian Coronaviruses in the Genus Deltacoronavirus Supports Bat Coronaviruses as the Gene Source of Alphacoronavirus and Betacoronavirus and Avian Coronaviruses as the Gene Source of Gammacoronavirus and Deltacoronavirus, Journal of Virology 2012; 86(7):3995–4008. https://doi.org/10.1128/JVI.06540-11.

Guan Y et al. Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China. Science 1979;302(5643):276–8. https://doi.org/10.1126/science.1087139.

Rettner R. Coronavirus variants: Facts about omicron, delta and other COVID-19 mutants. (Online Article). Avilable form: https://www.livescience.com/coronavirus-variants.html#section-omicron-variant-b-1-1-529. Last Accessed on [24th March, 2022].

Junejo Y, Ozaslan M, Safdar M, Khailany RA, Rehman S, Yousaf W, et al. Novel SARS-CoV-2/COVID-19: Origin, pathogenesis, genes and genetic variations, immune responses and phylogenetic analysis. Gene Reports 2020; 20:100752. https://doi.org/10.1016/j.genrep.2020.100752.

Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Singh Y, et al. Coronavirus Disease 2019–COVID-19, Clinical Microbiology Reviews 2020; 33(4). https://doi.org/10.1128/CMR.00028-20.

Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. Journal of Travel Medicine 2020. 27(2). https://doi.org/10.1093/jtm/taaa021.

Brian DA, Baric RS. Coronavirus Genome Structure and Replication. 2005:1–30. https://doi.org/10.1007/3-540-26765-4_1.

Shi ZL, Guo D, Rottier PJM. Coronavirus: epidemiology, genome replication and the interactions with their hosts. Virol Sin. 2016;31(1):1–2. https://doi.org/10.1007/s12250-016-3746-0.

Heyman D. The world need to learn how to live with Covid-19 says UK public health expert. (Online Article). Available from: https://news.ilri.org/2020/09/03/the-world-needs-to-learn-how-to-live-with-covid-19-says-uk-public-health-expert-david-heymann/ [Last Accessed on 21st July, 2022]

Bergmann CC, Silverman RH. COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies, Cleveland Clinic Journal of Medicine 2020; 87(6):321–7. https://doi.org/10.3949/ccjm.87a.20047.

Abduljalil JM. Abduljalil BM. Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view, New Microbes and New Infections 2020;35:100672. https://doi.org/10.1016/j.nmni.2020.100672.

WHO COVID-19 Dashboard, Jun. 11, 2022.

Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19). 2020; 324(8):782. https://doi.org/10.1001/jama.2020.12839.

Tarighi P, Eftekhari S, Chizari M, Sabernavaei M, Jafari D, Mirzabeigi P. A review of potential suggested drugs for coronavirus disease (COVID-19) treatment. European Journal of Pharmacology. 2021;895:173890, https://doi.org/10.1016/j.ejphar.2021.173890.

List of COVID-19 vaccine authorizations, https://en.wikipedia.org/wiki?curid=67134361.2022.

DOI: 10.26440/IHRJ/0605.08556
Published: 2022-08-30
How to Cite
Somenath Dutta, Rohan Ghosh, Debanjan Ghosh, Priyasa Santra, Shilpa Daw. A Detailed Study of Covid-19 (Emphasizing its Genomic Variants, Pathogenicity, Phylogenetic Analysis, Epidemiology, and Clinical Measures) . IHRJ [Internet]. 2022Aug.30 [cited 2022Dec.8];6(5):RV1-RV10. Available from: https://ihrjournal.com/ihrj/article/view/556